Related Experiment Video
Updated: May 16, 2025
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Calcific Aortic Valve Disease - From Mechanism to Treatment
Yuhe Chen1, Songhao Jia1,2,3, Jiawen Zhang1
1Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University.
Abstract:
Calcific aortic valve disease (CAVD) is one of the most prevalent heart valve diseases and is characterized by progressive stiffening and calcification of the aortic valve. For decades, CAVD has been treated with surgical intervention. In recent years, some progress has been made in understanding the pathogenesis of CAVD and the exploration of novel therapeutic strategies, leading to the identification of potential therapeutic targets and innovative treatment approaches. This review systematically outlines the pathophysiological advances in CAVD over the past 5 years, proposing a 3-stage model for disease progression: inflammatory, fibrotic, and calcification stages. In addition, recent clinical trials investigating pharmacological therapies, such as those targeting lipid metabolism, vitamin K pathways, and calcium-phosphorus balance, are summarized and discussed. These developments hold promise for improving patient outcomes and revolutionizing the management of CAVD.
Insights
Calcific aortic valve disease (CAVD) progresses through inflammatory, fibrotic, and calcification stages. Recent research explores novel therapies targeting lipid metabolism and calcium balance to improve CAVD management.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Translational Research
Background:
- Calcific aortic valve disease (CAVD) is a common heart valve condition marked by aortic valve stiffening and calcification.
- Current treatment for CAVD primarily involves surgical intervention.
- Recent advancements offer new insights into CAVD pathogenesis and potential therapeutic targets.
Purpose of the Study:
- To systematically review pathophysiological advances in CAVD over the last five years.
- To propose a novel 3-stage model for CAVD progression.
- To summarize and discuss recent clinical trials for pharmacological therapies in CAVD.
Main Methods:
- Systematic literature review of pathophysiological studies on CAVD.
- Analysis of recent clinical trials investigating pharmacological interventions.
- Synthesis of findings to propose a disease progression model.
Main Results:
- A 3-stage model of CAVD progression is proposed: inflammatory, fibrotic, and calcification stages.
- Recent research has identified potential therapeutic targets in lipid metabolism, vitamin K pathways, and calcium-phosphorus balance.
- Clinical trials are exploring novel pharmacological approaches for CAVD management.
Conclusions:
- Understanding CAVD pathogenesis has advanced significantly, leading to new therapeutic strategies.
- The proposed 3-stage model provides a framework for comprehending disease progression.
- Emerging pharmacological therapies show promise for revolutionizing CAVD patient outcomes and management.
